• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 10
      CHIP, mCAs, and Cancer Risk: What Weโ€™re Learning | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 7 month(s) ago

      CANCER Section Editor and Host Dr. Courtney DiNardo welcomes Dr. Pinkal Desai, Dr. Koichi Takahashi, and Ms. Nehali Shah to discuss new research on the impact of clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) on the risk and mortality of solid tumors like breast, lung, and colorectal cancer. Dr. Desai highlights findings from her recent study published in CANCER, while Dr. Takahashi and Ms. Shah share perspectives from their accompanying editorial. The episode explores the potential impact of these findings on clinical care and future research directions. Read Dr. Desaiโ€™s article: https://bit.ly/CHIPandmCAsonSolidTumorRisk Read the editorial by Dr. Takahashi and Ms. Shah: https://bit.ly/CHIPandmCAsEditorial Music by Ivymusic, obtained from Pixabay.

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        New CancerSpeak podcast! ๐Ÿ“—๐ŸŽ™๏ธ Join CANCER Section Editor Dr. Courtney DiNardo of @MDAndersonNews as she speaks w/ @DrPinkalDesai @DrKTakahashi & Ms. Nehali Shah about exciting new research on CHIP and mCAs on solid tumor risk. https://t.co/IqjiKHbDdz @OncoAlert https://t.co/yGfqrtJTzc

    • Mashup Score: 10
      CHIP, mCAs, and Cancer Risk: What Weโ€™re Learning | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 7 month(s) ago

      CANCER Section Editor and Host Dr. Courtney DiNardo welcomes Dr. Pinkal Desai, Dr. Koichi Takahashi, and Ms. Nehali Shah to discuss new research on the impact of clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) on the risk and mortality of solid tumors like breast, lung, and colorectal cancer. Dr. Desai highlights findings from her recent study published in CANCER, while Dr. Takahashi and Ms. Shah share perspectives from their accompanying editorial. The episode explores the potential impact of these findings on clinical care and future research directions. Read Dr. Desaiโ€™s article: https://bit.ly/CHIPandmCAsonSolidTumorRisk Read the editorial by Dr. Takahashi and Ms. Shah: https://bit.ly/CHIPandmCAsEditorial Music by Ivymusic, obtained from Pixabay.

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        New CancerSpeak podcast! ๐Ÿ“—๐ŸŽ™๏ธ Join CANCER Section Editor Dr. Courtney DiNardo of @MDAndersonNews as she speaks w/ @DrPinkalDesai @DrKTakahashi & Ms. Nehali Shah about exciting new research on CHIP and mCAs on solid tumor risk. https://t.co/IqjiKHbDdz @OncoAlert https://t.co/yGfqrtJTzc

    • Mashup Score: 15
      Key Highlights from ESMO 2024 โ€“ Shaping the Future of Clinical Oncology | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 8 month(s) ago

      In this special edition of CancerSpeak, CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan (Social Media Editor for CANCER), Dr. Jason Luke (Melanoma and Skin Section Editor for CANCER), and patient advocate Deborah Collyar to discuss key takeaways from the European Society for Medical Oncology (ESMO) 2024 Congress. From advances in melanoma and immunotherapy, to the role social media plays during clinical oncology meetings and in patient advocacy, this episode explores emerging developments that have the potential to impact clinical oncology practice and patient care. Learn more about Free Format submission with CANCER: https://bit.ly/CANCERFreeFormatSubmission Read an introductory editorial about Direct to CANCER: https://bit.ly/DirectToCANCER Music by Ivymusic, obtained from Pixabay.

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        ๐ŸŽ™๏ธ New CancerSpeak podcast alert! Join our EIC @RamalingamMD & guests @weoncologists @jasonlukemd @deborahcollyar as they recap key takeaways from #ESMO24, covering advances in melanoma & immunotherapy, & the role of #SoMe in clinical oncology. @OncoAlert https://t.co/C0u1CjyNB4

    • Mashup Score: 16
      Key Highlights from ESMO 2024 โ€“ Shaping the Future of Clinical Oncology | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 8 month(s) ago

      In this special edition of CancerSpeak, CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan (Social Media Editor for CANCER), Dr. Jason Luke (Melanoma and Skin Section Editor for CANCER), and patient advocate Deborah Collyar to discuss key takeaways from the European Society for Medical Oncology (ESMO) 2024 Congress. From advances in melanoma and immunotherapy, to the role social media plays during clinical oncology meetings and in patient advocacy, this episode explores emerging developments that have the potential to impact clinical oncology practice and patient care. Learn more about Free Format submission with CANCER: https://bit.ly/CANCERFreeFormatSubmission Read an introductory editorial about Direct to CANCER: https://bit.ly/DirectToCANCER Music by Ivymusic, obtained from Pixabay.

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        ๐ŸŽ™๏ธ New CancerSpeak podcast alert! Join our EIC @RamalingamMD & guests @weoncologists @jasonlukemd @deborahcollyar as they recap key takeaways from #ESMO24, covering advances in melanoma & immunotherapy, & the role of #SoMe in clinical oncology. @OncoAlert https://t.co/C0u1CjyNB4

    • Mashup Score: 16
      Key Highlights from ESMO 2024 โ€“ Shaping the Future of Clinical Oncology | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 8 month(s) ago

      In this special edition of CancerSpeak, CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan (Social Media Editor for CANCER), Dr. Jason Luke (Melanoma and Skin Section Editor for CANCER), and patient advocate Deborah Collyar to discuss key takeaways from the European Society for Medical Oncology (ESMO) 2024 Congress. From advances in melanoma and immunotherapy, to the role social media plays during clinical oncology meetings and in patient advocacy, this episode explores emerging developments that have the potential to impact clinical oncology practice and patient care. Learn more about Free Format submission with CANCER: https://bit.ly/CANCERFreeFormatSubmission Read an introductory editorial about Direct to CANCER: https://bit.ly/DirectToCANCER Music by Ivymusic, obtained from Pixabay.

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        ๐ŸŽ™๏ธ New CancerSpeak podcast alert! Join our EIC @RamalingamMD & guests @weoncologists @jasonlukemd @deborahcollyar as they recap key takeaways from #ESMO24, covering advances in melanoma & immunotherapy, & the role of #SoMe in clinical oncology. @OncoAlert https://t.co/C0u1CjyNB4

    • Mashup Score: 16
      Key Highlights from ESMO 2024 โ€“ Shaping the Future of Clinical Oncology | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 8 month(s) ago

      In this special edition of CancerSpeak, CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan (Social Media Editor for CANCER), Dr. Jason Luke (Melanoma and Skin Section Editor for CANCER), and patient advocate Deborah Collyar to discuss key takeaways from the European Society for Medical Oncology (ESMO) 2024 Congress. From advances in melanoma and immunotherapy, to the role social media plays during clinical oncology meetings and in patient advocacy, this episode explores emerging developments that have the potential to impact clinical oncology practice and patient care. Learn more about Free Format submission with CANCER: https://bit.ly/CANCERFreeFormatSubmission Read an introductory editorial about Direct to CANCER: https://bit.ly/DirectToCANCER Music by Ivymusic, obtained from Pixabay.

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        ๐ŸŽ™๏ธ New CancerSpeak podcast alert! Join our EIC @RamalingamMD & guests @weoncologists @jasonlukemd @deborahcollyar as they recap key takeaways from #ESMO24, covering advances in melanoma & immunotherapy, & the role of #SoMe in clinical oncology. @OncoAlert https://t.co/C0u1CjyNB4

    • Mashup Score: 17
      Top Advances in Cervical Cancer: A Year in Review | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 8 month(s) ago

      In this episode of CancerSpeak, Dr. Linda R. Duska, lead author of the recent article “Top Advances of the Year: Cervical Cancer,” joins host Dr. Akinyemi Ojesina and special guest Linda Ryan, a cervical cancer survivor and patient advocate, to discuss the latest breakthroughs in cervical cancer treatment. They explore the uniqueness of the SHAPE surgical de-escalation trial, the importance of increasing racial and geographical diversity in clinical trials, and key takeaways for patients with cervical cancer and their families. ย  Read the article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35334 ย  Music by Ivymusic, obtained from Pixabay

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        ๐ŸŽ™๏ธ New CancerSpeak episode alert! This episode dives into recent advances in #CervicalCancer treatment and research. Hear from survivor and patient advocate Linda Ryan, who shares her powerful story of her clinical trial experience. https://t.co/4oMLoKTkbc @OncoAlert #gyncsm https://t.co/zAl5tp55rm

    • Mashup Score: 16
      Top Advances in Cervical Cancer: A Year in Review | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 10 month(s) ago

      In this episode of CancerSpeak, Dr. Linda R. Duska, lead author of the recent article “Top Advances of the Year: Cervical Cancer,” joins host Dr. Akinyemi Ojesina and special guest Linda Ryan, a cervical cancer survivor and patient advocate, to discuss the latest breakthroughs in cervical cancer treatment. They explore the uniqueness of the SHAPE surgical de-escalation trial, the importance of increasing racial and geographical diversity in clinical trials, and key takeaways for patients with cervical cancer and their families. ย  Read the article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35334 ย  Music by Ivymusic, obtained from Pixabay

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        ๐ŸŽ™๏ธ New CancerSpeak episode alert! This episode dives into recent advances in #CervicalCancer treatment and research. Hear from survivor and patient advocate Linda Ryan, who shares her powerful story of her clinical trial experience. https://t.co/4oMLoKTkbc @OncoAlert #gyncsm https://t.co/zAl5tp55rm

    • Mashup Score: 14
      Top Advances in Cervical Cancer: A Year in Review | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 10 month(s) ago

      In this episode of CancerSpeak, Dr. Linda R. Duska, lead author of the recent article “Top Advances of the Year: Cervical Cancer,” joins host Dr. Akinyemi Ojesina and special guest Linda Ryan, a cervical cancer survivor and patient advocate, to discuss the latest breakthroughs in cervical cancer treatment. They explore the uniqueness of the SHAPE surgical de-escalation trial, the importance of increasing racial and geographical diversity in clinical trials, and key takeaways for patients with cervical cancer and their families. ย  Read the article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35334 ย  Music by Ivymusic, obtained from Pixabay

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        ๐ŸŽ™๏ธ New CancerSpeak episode alert! This episode dives into recent advances in #CervicalCancer treatment and research. Hear from survivor and patient advocate Linda Ryan, who shares her powerful story of her clinical trial experience. https://t.co/4oMLoKTkbc @OncoAlert #gyncsm https://t.co/zAl5tp55rm

    • Mashup Score: 11
      Top Advances in Cervical Cancer: A Year in Review | CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society - 11 month(s) ago

      In this episode of CancerSpeak, Dr. Linda R. Duska, lead author of the recent article “Top Advances of the Year: Cervical Cancer,” joins host Dr. Akinyemi Ojesina and special guest Linda Ryan, a cervical cancer survivor and patient advocate, to discuss the latest breakthroughs in cervical cancer treatment. They explore the uniqueness of the SHAPE surgical de-escalation trial, the importance of increasing racial and geographical diversity in clinical trials, and key takeaways for patients with cervical cancer and their families. ย  Read the article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35334 ย  Music by Ivymusic, obtained from Pixabay

      Source: cancerspeak.podbean.com
      Categories: General Medicine News, Oncologists1
      Tweet Tweets with this article
      • Profile photo of 	JournalCancer
        JournalCancer

        ๐ŸŽ™๏ธ New CancerSpeak episode alert! This episode dives into recent advances in #CervicalCancer treatment and research. Hear from survivor and patient advocate Linda Ryan, who shares her powerful story of her clinical trial experience. https://t.co/4oMLoKTkbc @OncoAlert #gyncsm https://t.co/zAl5tp55rm

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    ยฉ 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings